Published in Stem Cells on May 01, 2013
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells. Biomed Res Int (2014) 1.08
Targeting Aggressive Cancer Stem Cells in Glioblastoma. Front Oncol (2015) 1.05
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Dis (2015) 1.05
Emerging treatment strategies for glioblastoma multiforme. EMBO Mol Med (2014) 1.00
Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma. Neoplasia (2013) 0.95
Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1. Cell Death Differ (2014) 0.90
Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer (2013) 0.89
Glioma Stem Cells: Signaling, Microenvironment, and Therapy. Stem Cells Int (2016) 0.88
microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. Cell Mol Neurobiol (2014) 0.86
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells. PLoS One (2015) 0.86
Glioblastoma stem cells: Molecular characteristics and therapeutic implications. World J Stem Cells (2014) 0.86
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets. Stem Cells Int (2016) 0.85
Decoding the cancer stem cell hypothesis in glioblastoma. CNS Oncol (2013) 0.82
Targeted therapy against cancer stem cells. Oncol Lett (2015) 0.82
Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell Death Differ (2015) 0.82
Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells. PLoS One (2016) 0.82
Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells. PLoS One (2014) 0.81
Renal Cancer Stem Cells: Characterization and Targeted Therapies. Stem Cells Int (2016) 0.80
Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain. Int J Mol Sci (2015) 0.80
Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF). Cell Mol Neurobiol (2014) 0.79
Aggressive invasion is observed in CD133(-)/A2B5(+) glioma-initiating cells. Oncol Lett (2015) 0.78
Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma. Clin Med Insights Oncol (2015) 0.78
GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis (2016) 0.77
Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness. Oncotarget (2016) 0.75
Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients. PLoS One (2013) 0.75
Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma. PLoS One (2016) 0.75
The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis. Cancer Res (2016) 0.75
PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback. Oncogene (2015) 0.75
Ovarian cancer stem cells: still an elusive entity? Mol Cancer (2017) 0.75
Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer (2017) 0.75
High expression of miR-9 in CD133(+) glioblastoma cells in chemoresistance to temozolomide. J Cancer Stem Cell Res (2015) 0.75
Screening glioma stem cells in U251 cells based on the P1 promoter of the CD133 gene. Oncol Lett (2016) 0.75
n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma. Int J Mol Sci (2017) 0.75
The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies. Front Mol Biosci (2017) 0.75
Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc. J Neurooncol (2017) 0.75
MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma. Int J Mol Med (2017) 0.75
Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells. J Cancer (2017) 0.75
Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature. Cancer Genomics Proteomics (2017) 0.75
Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget (2017) 0.75
Spontaneous intracranial hypotension syndrome: a novel speculative physiopathological hypothesis and a novel patch method in a series of 28 consecutive patients. J Neurosurg (2010) 2.38
Coil embolization of left coronary artery pseudoaneurysms arising as a complication of percutaneous coronary intervention. Catheter Cardiovasc Interv (2012) 2.03
Functional disability after instrumented stabilization in lumbar degenerative spondylolisthesis: a follow-up study. Funct Neurol (2006) 2.00
Is fluorescein-guided technique able to help in resection of high-grade gliomas? Neurosurg Focus (2014) 1.74
Stent implantation for coarctation of the aorta in children <30 kg. JACC Cardiovasc Interv (2009) 1.71
Surgical site infections after elective neurosurgery: a survey of 1747 patients. Neurosurgery (2008) 1.66
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol (2007) 1.59
Image-guided endoscopic transnasal removal of recurrent pituitary adenomas. Neurosurgery (2002) 1.55
A novel impermeable adhesive membrane to reinforce dural closure: a preliminary retrospective study on 119 consecutive high-risk patients. World Neurosurg (2011) 1.53
Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery (2003) 1.41
Current strategies for identification of glioma stem cells: adequate or unsatisfactory? J Oncol (2012) 1.40
Percutaneous retrieval of the locked helex septal occluder. Catheter Cardiovasc Interv (2011) 1.38
The role of indocyanine green videoangiography (ICGV) in surgery of parasagittal meningiomas. Acta Neurochir (Wien) (2013) 1.38
Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases. Acta Neurochir (Wien) (2013) 1.34
Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J Biol Chem (2002) 1.31
Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma. J Neurooncol (2003) 1.30
Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology (2008) 1.23
Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology (2006) 1.19
Meningiomas invading the superior sagittal sinus: surgical experience in 108 cases. Neurosurgery (2004) 1.19
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood (2013) 1.19
Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res (2007) 1.19
A role for the transcription factor HEY1 in glioblastoma. J Cell Mol Med (2008) 1.16
Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord (2005) 1.13
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation. Dev Cell (2009) 1.07
Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Mol Cancer (2004) 1.06
Neuritis ossificans. J Neurosurg (2014) 1.06
Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus: an Italian multicenter study. Neurosurgery (2008) 1.06
Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol (2005) 1.01
Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue. J Anat (2007) 0.98
Intraoperative pulmonary artery stenting: an alternative technique for the management of pulmonary artery stenosis. Ann Thorac Surg (2007) 0.98
Cancer stem cell contribution to glioblastoma invasiveness. Stem Cell Res Ther (2013) 0.98
Microvascular decompression for glossopharyngeal neuralgia: a long-term retrospectic review of the Milan-Bologna experience in 31 consecutive cases. Acta Neurochir (Wien) (2009) 0.97
CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol (2004) 0.97
Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery. Neurol Sci (2009) 0.97
Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients. J Neurooncol (2004) 0.96
Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma. Neoplasia (2013) 0.95
Brainstem cavernomas: long-term results of microsurgical resection in 52 patients. Neurosurgery (2005) 0.95
Cyberknife radiosurgery for trigeminal neuralgia treatment: a preliminary multicenter experience. Neurosurgery (2008) 0.95
Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci (2009) 0.94
Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience. Neurosurg Rev (2009) 0.94
Venous sacrifice in neurosurgery: new insights from venous indocyanine green videoangiography. J Neurosurg (2011) 0.93
Adipose-derived stem cell therapy for intervertebral disc regeneration: an in vitro reconstructed tissue in alginate capsules. Tissue Eng Part A (2008) 0.92
Brain surgery in a stereoscopic virtual reality environment: a single institution's experience with 100 cases. Neurosurgery (2010) 0.92
Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci (2010) 0.91
Deep brain stimulation of the posteromedial hypothalamus: indications, long-term results, and neurophysiological considerations. Neurosurg Focus (2010) 0.91
CyberKnife radiosurgery as a first treatment for idiopathic trigeminal neuralgia. Neurosurgery (2009) 0.91
Aphasia induced by gliomas growing in the ventrolateral frontal region: assessment with diffusion MR tractography, functional MR imaging and neuropsychology. Cortex (2011) 0.91
Association of chromosome 10 losses and negative prognosis in oligoastrocytomas. Ann Neurol (2002) 0.91
Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases. Neurol Sci (2012) 0.90
Deep-brain stimulation for aggressive and disruptive behavior. World Neurosurg (2012) 0.90
Hemispherotomy and functional hemispherectomy: indications and outcome. Epilepsy Res (2009) 0.89
Aorto-left ventricular tunnel: an alternative surgical approach. Ann Thorac Surg (2006) 0.89
Occipital nerve stimulation (ONS). Surgical technique and prevention of late electrode migration. Acta Neurochir (Wien) (2009) 0.88
Regression of pulmonary arteriovenous malformations after transcatheter reconnection of the pulmonary arteries in patients with unidirectional Fontan. Congenit Heart Dis (2008) 0.88
Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia. Report of two cases. J Neurosurg (2005) 0.87
Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer (2010) 0.87
Molecular networks in melanoma invasion and metastasis. Future Oncol (2013) 0.87
Treatment of chronic headache of cervical origin with lipostructure: an observational study. Headache (2012) 0.87
Staged repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 104 patients. J Thorac Cardiovasc Surg (2003) 0.87
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts. Neurobiol Aging (2006) 0.87
A simple method to assess accuracy of deep brain stimulation electrode placement: pre-operative stereotactic CT + postoperative MR image fusion. Stereotact Funct Neurosurg (2004) 0.86
Reclassification of oligoastrocytomas by loss of heterozygosity studies. Int J Cancer (2006) 0.86
Fluorescein-guided surgery for malignant gliomas: a review. Neurosurg Rev (2014) 0.85
Cranial nerve hemangioblastoma. J Neurosurg (2003) 0.85
Stimulation of occipital nerve for drug-resistant chronic cluster headache. Lancet Neurol (2007) 0.85
Functional role of CLIC1 ion channel in glioblastoma-derived stem/progenitor cells. J Natl Cancer Inst (2013) 0.85
The Rai (Shc C) adaptor protein regulates the neuronal stress response and protects against cerebral ischemia. Proc Natl Acad Sci U S A (2004) 0.85
Stimulation of the posterior hypothalamus for medically intractable impulsive and violent behavior. Stereotact Funct Neurosurg (2005) 0.85
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival? J Neurooncol (2008) 0.84
Characterization of cluster-assembled nanostructured titanium oxide coatings as substrates for protein arrays. Anal Biochem (2009) 0.84
Vagal nerve stimulation: relationship between outcome and electroclinical seizure pattern. Seizure (2006) 0.83
Rai is a new regulator of neural progenitor migration and glioblastoma invasion. Stem Cells (2012) 0.83
Vagus nerve stimulation in refractory epilepsy: new indications and outcome assessment. Epilepsy Behav (2013) 0.83
Vertebroplasty for pain relief and spinal stabilization in multiple myeloma. Neurol Sci (2010) 0.83
Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients. J Neural Transm (Vienna) (2011) 0.82
Chronic motor cortex stimulation for movement disorders: a promising perspective. Neurol Res (2003) 0.82
Microvascular decompression for neurovascular conflicts in the cerebello-pontine angle: which role for endoscopy? Acta Neurochir (Wien) (2013) 0.82
Multisession radiosurgery for optic nerve sheath meningiomas--an effective option: preliminary results of a single-center experience. Neurosurgery (2011) 0.82
Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas. J Neurooncol (2005) 0.82
Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation. J Biol Chem (2003) 0.82
Deep brain stimulation and frameless stereotactic radiosurgery in the treatment of bilateral parkinsonian tremor: target selection and case report of two patients. Acta Neurochir (Wien) (2011) 0.81
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. Oncogene (2005) 0.81
Minimally invasive disc preserving surgery in cervical radiculopathies: the posterior microscopic and endoscopic approach. Acta Neurochir Suppl (2011) 0.81
Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study. Tumori (2010) 0.81
Management of chronic cluster headache. Curr Treat Options Neurol (2011) 0.81
Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma. J Neurooncol (2005) 0.80
Developmental venous anomaly of petrous veins: intraoperative findings and indocyanine green video angiographic study. Neurosurgery (2008) 0.80
Craniotomy using image-guided oscillating saw: technical note. Neurol Res (2006) 0.80
Advanced 3-dimensional planning in neurosurgery. Neurosurgery (2013) 0.80
Arteriovenous micromalformation of the trigeminal root: intraoperative diagnosis with indocyanine green videoangiography: case report. Neurosurgery (2010) 0.80
Spinal cord compression: an unusual presentation of malignant pleural mesothelioma. A case report and review of the literature. Tumori (2012) 0.80
What is the best timing for fluorescein injection during surgical removal of high-grade gliomas? Acta Neurochir (Wien) (2015) 0.80
Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg (2011) 0.80